OQROGet OQRO Pro
Insider trade

Newamsterdam Pharma Co N.V. (NAMS)10% owner sold ~$1.08M

ForGrowth NAP B.V., 10% owner at Newamsterdam Pharma Co N.V., sold ~$1.08M of Newamsterdam Pharma Co N.V. shares.

~$1.08M
Approx. value · 41K sh @ $25.95
10.7M
Holds after · shares reported
Traded
Dec 27, 2024
Filed
Dec 30, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 13, 2024Insider10% owner sold ~$27K of NAMS shares in the open market
  2. Nov 14, 2024Insider10% owner sold ~$246K of NAMS shares in the open market
  3. Nov 15, 2024Insider10% owner sold ~$213K of NAMS shares in the open market
  4. Nov 18, 2024Insider10% owner sold ~$834K of NAMS shares in the open market
  5. Dec 10, 2024Insider · 1 personInsiders: 2 sales (~$7.8M)
  6. Dec 11, 2024Insider · 1 personInsiders: 3 sales (~$3.9M)
  7. Dec 12, 2024Insider · 1 personInsiders: 2 sales (~$4.2M)
  8. Dec 13, 2024Insider10% owner sold ~$644K of NAMS shares in the open market
  9. Dec 16, 2024Insider10% owner sold ~$27K of NAMS shares in the open market
  10. Dec 17, 2024Insider · 1 personInsiders: 2 sales (~$3.0M)
  11. Dec 18, 2024Insider · 1 personInsiders: 2 sales (~$2.6M)
  12. Dec 19, 2024Insider10% owner sold ~$1.44M of NAMS shares in the open market
  13. Dec 20, 2024Insider · 1 personInsiders: 2 sales (~$1.3M)
  14. Dec 23, 2024Insider10% owner sold ~$641K of NAMS shares in the open market
  15. Dec 24, 2024Insider10% owner sold ~$415K of NAMS shares in the open market
  16. Dec 26, 2024Insider10% owner sold ~$870K of NAMS shares in the open market
  17. Dec 27, 2024 · this disclosureInsider10% owner sold ~$1.08M of NAMS shares in the open market

What came next

  1. Dec 30, 2024Insider10% owner sold ~$762K of NAMS shares in the open market
  2. Mar 4, 2025Insider · 2 peopleInsiders: 1 purchase (~$84K), 1 sale (~$3.1M)
  3. Mar 26, 2025InsiderDirector purchased ~$26K of NAMS shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Newamsterdam Pharma Co N.V.

For Newamsterdam Pharma Co N.V., OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NAMS page.

Other recent filings by ForGrowth NAP B.V., 10% owner

The full history of ForGrowth NAP B.V., 10% owner is on the profile page.

How this filing works

Other disclosures at Newamsterdam Pharma Co N.V.

Everything OQRO holds on this company is on its NAMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data